Study: Pfizer lung cancer pill may double survival - The Associated Press

[INCIID News Feed]

KEPR 19
<img alt="" height="1" width="1" />
Study: Pfizer lung cancer pill may double survival
The Associated Press
TRENTON, NJ (AP) — A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to research presented Sunday. The drug, called crizotinib, ...
Targeted drugs aid in cancer treatmentBoston Globe
ASCO roundup: Fresh progress of Merck, Pfizer cancer drugsFierceBiotech
Lung cancer drug crizotinib sharply increases survival in patients with a ...Los Angeles Times
DailyIndia.com -Forbes (blog) -Motley Fool
all 230 news articles &raquo;


More...